Stock FONR FONAR CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials FONAR Corporation

Equities

FONR

US3444374058

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
16.27 USD -3.50% Intraday chart for FONAR Corporation -3.21% -16.82%
Feb. 14 Tranche Update on FONAR Corporation's Equity Buyback Plan announced on September 29, 2022. CI
Feb. 14 FONAR Corporation Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023 CI

Valuation

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Capitalization 1 170.3 139.5 140.5 118.1 101.5 114
Enterprise Value (EV) 1 151.2 110.8 139.5 108.3 90.96 99.68
P/E ratio 8.42 x 9.55 x 17.9 x 12.1 x 8.54 x 12.6 x
Yield - - - - - -
Capitalization / Revenue 1.71 x 1.6 x 1.64 x 1.31 x 1.04 x 1.16 x
EV / Revenue 1.52 x 1.27 x 1.63 x 1.2 x 0.93 x 1.01 x
EV / EBITDA 6.46 x 4.27 x 7.94 x 5.12 x 3.43 x 5.16 x
EV / FCF 15.9 x 15.9 x 23.8 x 11.7 x 11.3 x 12.3 x
FCF Yield 6.31% 6.28% 4.21% 8.56% 8.88% 8.13%
Price to Book 1.73 x 1.2 x 1.11 x 0.85 x 0.68 x 0.71 x
Nbr of stocks (in thousands) 6,415 6,485 6,575 6,682 6,682 6,666
Reference price 2 26.55 21.51 21.37 17.68 15.19 17.10
Announcement Date 9/21/18 9/30/19 10/1/20 10/13/21 9/28/22 9/28/23
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Juni 2018 2019 2020 2021 2022 2023
Net sales 1 99.41 87.19 85.69 89.93 97.59 98.65
EBITDA 1 23.41 25.97 17.56 21.18 26.54 19.33
EBIT 1 19.68 22.13 13.65 17.1 22.01 14.79
Operating Margin 19.8% 25.39% 15.93% 19.01% 22.55% 14.99%
Earnings before Tax (EBT) 1 19.78 22.52 14.15 17.67 22.77 15.76
Net income 1 21.23 15.32 8.24 10.21 12.44 9.376
Net margin 21.36% 17.57% 9.62% 11.35% 12.75% 9.5%
EPS 2 3.155 2.253 1.196 1.459 1.778 1.360
Free Cash Flow 1 9.531 6.955 5.867 9.269 8.079 8.101
FCF margin 9.59% 7.98% 6.85% 10.31% 8.28% 8.21%
FCF Conversion (EBITDA) 40.71% 26.78% 33.41% 43.77% 30.44% 41.91%
FCF Conversion (Net income) 44.89% 45.41% 71.2% 90.81% 64.94% 86.4%
Dividend per Share - - - - - -
Announcement Date 9/21/18 9/30/19 10/1/20 10/13/21 9/28/22 9/28/23
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 19.2 28.7 1.06 9.8 10.5 14.3
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 9.53 6.96 5.87 9.27 8.08 8.1
ROE (net income / shareholders' equity) 27.5% 18.6% 9.58% 10.5% 12.2% 8.16%
ROA (Net income/ Total Assets) 11.3% 11% 5.44% 5.78% 7.07% 4.62%
Assets 1 187.3 139.4 151.5 176.6 175.9 202.8
Book Value Per Share 2 15.40 17.90 19.20 20.70 22.50 24.00
Cash Flow per Share 2 3.060 2.140 5.600 6.650 7.290 7.800
Capex 1 2.78 3.36 7.52 3.53 4.55 4.22
Capex / Sales 2.79% 3.85% 8.78% 3.93% 4.66% 4.28%
Announcement Date 9/21/18 9/30/19 10/1/20 10/13/21 9/28/22 9/28/23
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
FONAR CORPORATION Stock FONAR Corporation
-16.82% 105M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+8.07% 219B
DANAHER CORPORATION Stock Danaher Corporation
+6.59% 183B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+11.26% 133B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+26.57% 108B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+0.65% 63.06B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+13.35% 52.02B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-0.62% 48.2B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-0.93% 40.37B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
+11.54% 39.35B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. FONR Stock
  4. Financials FONAR Corporation